Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

NCT04941365 is registered in ClinicalTrials.gov with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor.

NCT NCT04941365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04941365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Lead sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Phase
Not applicable
Overall status
Withdrawn
Start date
July 7, 2022
Completion date
March 31, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced renal cell carcinoma, healthy, metastatic breast cancer, metastatic melanoma, non-small cell lung cancer stage iii, squamous cell carcinoma of head and neck